527 related articles for article (PubMed ID: 20021214)
21. Targeting monocarboxylate transporters (MCTs) in cancer: How close are we to the clinics?
Singh M; Afonso J; Sharma D; Gupta R; Kumar V; Rani R; Baltazar F; Kumar V
Semin Cancer Biol; 2023 May; 90():1-14. PubMed ID: 36706846
[TBL] [Abstract][Full Text] [Related]
22. Disruption of BASIGIN decreases lactic acid export and sensitizes non-small cell lung cancer to biguanides independently of the LKB1 status.
Granja S; Marchiq I; Le Floch R; Moura CS; Baltazar F; Pouysségur J
Oncotarget; 2015 Mar; 6(9):6708-21. PubMed ID: 25894929
[TBL] [Abstract][Full Text] [Related]
23. Co-expression of CD147 (EMMPRIN), CD44v3-10, MDR1 and monocarboxylate transporters is associated with prostate cancer drug resistance and progression.
Hao J; Chen H; Madigan MC; Cozzi PJ; Beretov J; Xiao W; Delprado WJ; Russell PJ; Li Y
Br J Cancer; 2010 Sep; 103(7):1008-18. PubMed ID: 20736947
[TBL] [Abstract][Full Text] [Related]
24. Monocarboxylate transporters in the brain and in cancer.
Pérez-Escuredo J; Van Hée VF; Sboarina M; Falces J; Payen VL; Pellerin L; Sonveaux P
Biochim Biophys Acta; 2016 Oct; 1863(10):2481-97. PubMed ID: 26993058
[TBL] [Abstract][Full Text] [Related]
25. Cellular expression of the monocarboxylate transporter (MCT) family in the placenta of mice.
Nagai A; Takebe K; Nio-Kobayashi J; Takahashi-Iwanaga H; Iwanaga T
Placenta; 2010 Feb; 31(2):126-33. PubMed ID: 20022372
[TBL] [Abstract][Full Text] [Related]
26. Radiosynthesis and validation of (±)-[18F]-3-fluoro-2-hydroxypropionate ([18F]-FLac) as a PET tracer of lactate to monitor MCT1-dependent lactate uptake in tumors.
Van Hée VF; Labar D; Dehon G; Grasso D; Grégoire V; Muccioli GG; Frédérick R; Sonveaux P
Oncotarget; 2017 Apr; 8(15):24415-24428. PubMed ID: 28107190
[TBL] [Abstract][Full Text] [Related]
27. Hypoxia, cancer metabolism and the therapeutic benefit of targeting lactate/H(+) symporters.
Marchiq I; Pouysségur J
J Mol Med (Berl); 2016 Feb; 94(2):155-71. PubMed ID: 26099350
[TBL] [Abstract][Full Text] [Related]
28. Role of monocarboxylate transporters in human cancers: state of the art.
Pinheiro C; Longatto-Filho A; Azevedo-Silva J; Casal M; Schmitt FC; Baltazar F
J Bioenerg Biomembr; 2012 Feb; 44(1):127-39. PubMed ID: 22407107
[TBL] [Abstract][Full Text] [Related]
29. Disruption of the monocarboxylate transporter-4-basigin interaction inhibits the hypoxic response, proliferation, and tumor progression.
Voss DM; Spina R; Carter DL; Lim KS; Jeffery CJ; Bar EE
Sci Rep; 2017 Jun; 7(1):4292. PubMed ID: 28655889
[TBL] [Abstract][Full Text] [Related]
30. Sex Hormones Regulate Rat Hepatic Monocarboxylate Transporter Expression and Membrane Trafficking.
Cao J; Ng M; Felmlee MA
J Pharm Pharm Sci; 2017; 20(1):435-444. PubMed ID: 29249221
[TBL] [Abstract][Full Text] [Related]
31. Significance of glycolytic metabolism-related protein expression in colorectal cancer, lymph node and hepatic metastasis.
Martins SF; Amorim R; Viana-Pereira M; Pinheiro C; Costa RF; Silva P; Couto C; Alves S; Fernandes S; Vilaça S; Falcão J; Marques H; Pardal F; Rodrigues M; Preto A; Reis RM; Longatto-Filho A; Baltazar F
BMC Cancer; 2016 Jul; 16():535. PubMed ID: 27460659
[TBL] [Abstract][Full Text] [Related]
32. Role of monocarboxylate transporters in regulating metabolic homeostasis in the outer retina: Insight gained from cell-specific Bsg deletion.
Han JYS; Kinoshita J; Bisetto S; Bell BA; Nowak RA; Peachey NS; Philp NJ
FASEB J; 2020 Apr; 34(4):5401-5419. PubMed ID: 32112484
[TBL] [Abstract][Full Text] [Related]
33. Basigin (CD147) is the target for organomercurial inhibition of monocarboxylate transporter isoforms 1 and 4: the ancillary protein for the insensitive MCT2 is EMBIGIN (gp70).
Wilson MC; Meredith D; Fox JE; Manoharan C; Davies AJ; Halestrap AP
J Biol Chem; 2005 Jul; 280(29):27213-21. PubMed ID: 15917240
[TBL] [Abstract][Full Text] [Related]
34. Preconditioning-Induced Facilitation of Lactate Release from Astrocytes Is Essential for Brain Ischemic Tolerance.
Hirayama Y; Le HPN; Hashimoto H; Ishii I; Koizumi S; Anzai N
eNeuro; 2024 Apr; 11(4):. PubMed ID: 38604775
[TBL] [Abstract][Full Text] [Related]
35. MCT1 and MCT4 expression during myocardial ischemic-reperfusion injury in the isolated rat heart.
Zhu Y; Wu J; Yuan SY
Cell Physiol Biochem; 2013; 32(3):663-74. PubMed ID: 24030048
[TBL] [Abstract][Full Text] [Related]
36. Expression of monocarboxylate transporters I and IV and the ancillary protein CD147 in the intestinal tract of healthy horses and ponies.
Mykkänen AK; Niku M; Ilves M; Koho NM
Am J Vet Res; 2015 Feb; 76(2):161-9. PubMed ID: 25629914
[TBL] [Abstract][Full Text] [Related]
37. Lactate shuttles at a glance: from physiological paradigms to anti-cancer treatments.
Draoui N; Feron O
Dis Model Mech; 2011 Nov; 4(6):727-32. PubMed ID: 22065843
[TBL] [Abstract][Full Text] [Related]
38. Differential Expression of Monocarboxylate Transporter 1 and Ancillary Protein CD147 in Red Blood Cells of Show Jumping Horses.
Júnior WHF; Garcia de Carvalho JR; Mendes de Almeida ML; Macedo Lemos EG; Brioschi Soares OA; Ribeiro G; de Queiroz-Neto A; de Camargo Ferraz G
J Equine Vet Sci; 2019 Oct; 81():102791. PubMed ID: 31668305
[TBL] [Abstract][Full Text] [Related]
39. CAIX forms a transport metabolon with monocarboxylate transporters in human breast cancer cells.
Ames S; Andring JT; McKenna R; Becker HM
Oncogene; 2020 Feb; 39(8):1710-1723. PubMed ID: 31723238
[TBL] [Abstract][Full Text] [Related]
40. Monocarboxylate transporter 1 is a key player in glioma-endothelial cell crosstalk.
Miranda-Gonçalves V; Bezerra F; Costa-Almeida R; Freitas-Cunha M; Soares R; Martinho O; Reis RM; Pinheiro C; Baltazar F
Mol Carcinog; 2017 Dec; 56(12):2630-2642. PubMed ID: 28762551
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
